Table 9.
Previous studies investigating the mechanisms by which anticancer drugs exert their effects.
Mechanism of CIPNP | Neuropathic Pain Model | Mode of Administration/Concentration | Animal | Reference |
---|---|---|---|---|
Downregulation of MnSOD through post translational nitration by peroxynitrite. | Paclitaxel, oxaliplatin, bortezomib | Intraperitoneal; Paclitaxel: 4 doses delivered on alternate days, cumulative dose of 8 mg/kg Oxaliplatin: 10 mg/kg delivered over 5 consecutive days Bortezomib: 1 mg/kg delivered over 5 consecutive days |
Male Sprague Dawley rats | [91] |
Formation of DNA adducts | Cisplatin | 2 microgram/ml for 48 h (in vitro) | Harlan–Sprague–Dawley rats and wild type background mice (C57BL/6J) | [85] |
Increased permeability of mPTP | Paclitaxel | Intraperitoneal/ 1 ml/kg on 4 alternate days (in vitro and in vivo) |
Adult male Sprague–Dawley rats | [92] |
Increased LPS-induced iNOS expression | Oxaliplatin | i.v./nine injections of 1 mg/kg each given twice a week (in vitro and in vivo) |
male Swiss mice | [56] |